
Aide Health is a UK-based digital health platform focused on improving management of long-term conditions through a patient-clinician collaborative approach. The platform offers multiple apps supporting comorbidity, enabling patients to manage their prescribed care daily with natural language-driven conversations and real-world data insights. It helps clinicians optimize therapeutic effectiveness, improve clinical decision-making, and reduce clinical time by providing actionable patient data and automated medicine reminders. Aide is designed to support whole-person care rather than disease-specific care, addressing a critical healthcare challenge globally. The company is recognized for saving significant clinical time, such as 332.3 hours per 1,000 asthma patients, and is compliant with NHS data security standards, serving NHS, healthcare providers, employers, and individuals. It is backed by leading UK and European venture capital funds and research organizations.

Aide Health is a UK-based digital health platform focused on improving management of long-term conditions through a patient-clinician collaborative approach. The platform offers multiple apps supporting comorbidity, enabling patients to manage their prescribed care daily with natural language-driven conversations and real-world data insights. It helps clinicians optimize therapeutic effectiveness, improve clinical decision-making, and reduce clinical time by providing actionable patient data and automated medicine reminders. Aide is designed to support whole-person care rather than disease-specific care, addressing a critical healthcare challenge globally. The company is recognized for saving significant clinical time, such as 332.3 hours per 1,000 asthma patients, and is compliant with NHS data security standards, serving NHS, healthcare providers, employers, and individuals. It is backed by leading UK and European venture capital funds and research organizations.
Founded: 2021
Headquarters: United Kingdom
Core product: Aide — conversational-AI platform linking clinician web tool and patient mobile app
Use cases: Long-term condition management (asthma, type 2 diabetes, hypertension)
Notable traction: Used within NHS Primary Care Networks; registered as UK Class I medical device (Dec 2024)
Team size (reported): 23 employees
Long-term condition self-management and clinician–patient collaboration
2021
Digital health / Healthtech
1200000.00
Announced October/November 2022; reported ~US$1.2M
“Backed by multiple UK and European VC funds and angel investors (named participants include Salica/Hambro Perks, Fuel Ventures, 1818 Venture Capital, APX, ZEMU)”